November 2019
Corporate Newsletter
November 2019 | Issue 3
Working for Veterans Everywhere
$2.2M Series A Fundraising efforts continue
Bach Pharma is in the midst of a $2.2M capital raise in order to fund the next stage of preclinical testing, specifically a toxicology study for the Veteran's Administration. Individual Investors, Foundations and Veteran Organizations have already committed over $500,000 to this project. Once the toxicology studies are completed, Bach will qualify for an additional $8 million commitment from the US Department of Defense for additional testing of GVT.

If you are interested in increasing your shares in Bach Pharma as part of this program, please reach out to Christopher LaFarge or Mark Henry for more information.
Spotlight on our Contributors
Dr. Paul K.Y. Wong - Bach Pharma Inc. Scientific Advisor
Through the generosity and coordination with The Longevity Foundation , Dr. Paul K. Y. Wong is the due diligence expert for potential investors for Bach Pharma Inc. As part of The Longevity Foundation, Dr. Wong is their scientific advisor and generously donates his time to assist Bach Pharma by answering questions of potential investors.

Dr. Wong is formerly a professor in the Department of Carcinogenesis at The University of Texas M.D. Anderson Cancer Center. He is also a part of the Neurodegeneration Research Team at Bach Pharma, Inc. and has extensive research experience involving the mechanisms of retroviral-induced and defective gene-mediated neurodegeneration and cancer.

Dr. Wong has also served as an adjunct professor in the Graduate School of Biomedical Sciences at The University of Texas Health Science Center and the Department of Veterinary Microbiology at Texas A&M University. At The University of Texas at Austin, Dr. Wong has taught as an adjunct professor in the Department of Microbiology, the Institute of Molecular Biology, the Division of Pharmacology and Toxicology, and the Institute for Neuroscience.

Through his many teaching appointments, Dr. Wong has won the Dean’s Teaching Excellence Award. In addition to authoring over 220 publications, in 1998 Dr. Wong, along with Dr. William S. Lynn, co-edited and co-contributed chapters in a pivotal book entitled "Neuroimmuno-degeneration", a term they also created to describe the diseases in which immune and neural cells die prematurely.

Dr. Wong received his BS in Microbiology, his MS in Animal Virology and Genetics, and his PhD in Viral Genetics from the University of Manitoba in Canada. He completed a postdoctoral appointment at the University of Western Ontario studying retrovirology and cancer.